Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank33
3Y CAGR-55.1%
5Y CAGR-23.0%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-55.1%/yr
Annual compound
5Y CAGR
-23.0%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 26.92% |
| 2024 | 34.10% |
| 2023 | 10.57% |
| 2022 | 296.81% |
| 2021 | 193.00% |
| 2020 | 99.47% |
| 2019 | 0.00% |